Provides genetic testing and diagnostics services, focusing on reproductive health and oncology.
Natera, Inc. is a pioneering diagnostics company renowned for its global leadership in molecular testing services. Specializing in a wide array of innovative products, Natera offers advanced solutions that span across various stages of life and health. Its flagship offerings include Panorama, a non-invasive prenatal test that screens for fetal chromosomal abnormalities with a simple blood draw from expectant mothers. Additionally, Natera provides Vistara for single-gene disorder screening, Horizon carrier screening for genetic diseases, and Spectrum for identifying genetic conditions during IVF cycles. The company's comprehensive portfolio also encompasses Anora miscarriage tests and non-invasive paternity testing solutions.
Beyond diagnostics, Natera is at the forefront of technological innovation with products like Constellation, a cloud-based software empowering laboratories to leverage advanced algorithms and bioinformatics. Their groundbreaking Signatera technology utilizes circulating tumor DNA to monitor cancer mutations independently of specific tumor characteristics, while Prospera serves to assess organ transplant rejection. Natera distributes its products through direct sales efforts and a robust network of approximately 100 laboratory and distribution partners worldwide. Collaborative agreements with industry leaders such as BGI Genomics and Foundation Medicine underscore Natera's commitment to advancing genetic testing and personalized medicine. Founded in 2003 as Gene Security Network, Inc. and rebranded in 2012, Natera, Inc. is headquartered in Austin, Texas, driving forward the frontier of molecular diagnostics and personalized healthcare.
Natera, Inc. is a prominent diagnostics company recognized globally for its cutting-edge molecular testing services. Specializing in a diverse range of advanced diagnostic solutions, Natera offers innovative products that cater to various stages of health and wellness. Among its flagship offerings is Panorama, a non-invasive prenatal test that detects fetal chromosomal abnormalities using a simple blood draw from expectant mothers. The company also provides Vistara for single-gene disorder screening, Horizon carrier screening for genetic diseases, and Spectrum for identifying genetic conditions during IVF cycles. Additionally, Natera offers Anora miscarriage tests and non-invasive paternity testing solutions.
Natera, Inc. stands as a pioneering force in the field of diagnostics, specializing in molecular testing services that set global standards. The company's comprehensive portfolio includes groundbreaking products designed to address diverse healthcare needs at various stages of life. Panorama, for instance, is a non-invasive prenatal test that screens for fetal chromosomal abnormalities with a simple blood draw from expectant mothers. Additionally, Natera offers Vistara for single-gene disorder screening, Horizon carrier screening for genetic diseases, and Spectrum for identifying genetic conditions during IVF cycles. The company also provides Anora miscarriage tests and non-invasive paternity testing solutions.